Eton Pharmaceuticals Investor Relations Material
Latest events
Q1 2024
Eton Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Eton Pharmaceuticals Inc
Access all reports
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. Its lead product candidate is Etonogestrel/Ethinyl Estradiol (ETN/EE) Vaginal Contraceptive System (VCS), an FDA approved Class 4 non-biodegradable contraceptive vaginal ring for the treatment of female contraception. The company was founded in 2013 and is based in Bloomingdale, Illinois.
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
ETON
Country
đșđž United States